| Product Code: ETC12465524 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Immunotherapy Drugs Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Immunotherapy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Immunotherapy Drugs Market - Industry Life Cycle |
3.4 Vietnam Immunotherapy Drugs Market - Porter's Five Forces |
3.5 Vietnam Immunotherapy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Vietnam Immunotherapy Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Vietnam Immunotherapy Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Vietnam Immunotherapy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.9 Vietnam Immunotherapy Drugs Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Vietnam Immunotherapy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in Vietnam |
4.2.2 Growing awareness about immunotherapy treatment options |
4.2.3 Supportive government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost of immunotherapy drugs |
4.3.2 Limited access to advanced healthcare facilities in rural areas |
5 Vietnam Immunotherapy Drugs Market Trends |
6 Vietnam Immunotherapy Drugs Market, By Types |
6.1 Vietnam Immunotherapy Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Checkpoint Inhibitors, 2021 - 2031F |
6.1.4 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.5 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Cancer Vaccines, 2021 - 2031F |
6.1.6 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Cytokines, 2021 - 2031F |
6.1.7 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Adoptive T-Cell Therapy, 2021 - 2031F |
6.2 Vietnam Immunotherapy Drugs Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Melanoma, 2021 - 2031F |
6.2.5 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F |
6.2.6 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Multiple Myeloma, 2021 - 2031F |
6.3 Vietnam Immunotherapy Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Oncology Centers, 2021 - 2031F |
6.3.3 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.6 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Vietnam Immunotherapy Drugs Market, By Mechanism of Action |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Immunotherapy Drugs Market Revenues & Volume, By PD-1/PD-L1 Blocking, 2021 - 2031F |
6.4.3 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Immune System Activation, 2021 - 2031F |
6.4.4 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Tumor Cell Recognition, 2021 - 2031F |
6.4.5 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Signal Pathway Modulation, 2021 - 2031F |
6.4.6 Vietnam Immunotherapy Drugs Market Revenues & Volume, By CAR-T Cell Therapy, 2021 - 2031F |
6.5 Vietnam Immunotherapy Drugs Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.4 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Wholesale Suppliers, 2021 - 2031F |
6.5.5 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Government Procurement, 2021 - 2031F |
6.5.6 Vietnam Immunotherapy Drugs Market Revenues & Volume, By Hospital Contracts, 2021 - 2031F |
7 Vietnam Immunotherapy Drugs Market Import-Export Trade Statistics |
7.1 Vietnam Immunotherapy Drugs Market Export to Major Countries |
7.2 Vietnam Immunotherapy Drugs Market Imports from Major Countries |
8 Vietnam Immunotherapy Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for immunotherapy drugs in Vietnam |
8.2 Percentage of oncologists recommending immunotherapy treatments |
8.3 Patient survival rates post-immunotherapy treatment |
9 Vietnam Immunotherapy Drugs Market - Opportunity Assessment |
9.1 Vietnam Immunotherapy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Vietnam Immunotherapy Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Vietnam Immunotherapy Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Vietnam Immunotherapy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.5 Vietnam Immunotherapy Drugs Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Vietnam Immunotherapy Drugs Market - Competitive Landscape |
10.1 Vietnam Immunotherapy Drugs Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Immunotherapy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here